The National MS Society is partnering with the iConquerMS Patient-Powered Research Network to gather data on how well the COVID-19 vaccine is tolerated in the MS population. COVER-MS a study that assesses the experiences of those diagnosed with MS who received the COVID-19 vaccines. People with MS who have received the vaccine can visit the iConquerMS website to share their experience.